Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients

M. Broggini, G. Buraggi, A. Brenna, L. Riva, A. M. Codegoni, V. Torri, A. A. Lissoni, C. Mangioni, M. D'Incalci

Research output: Contribution to journalArticle

Abstract

Alterations in cell cycle regulating proteins are common in many cancer types. Recent data suggest a possible link between CDC25 phosphatases overexpression and malignancy. Our objective was to evaluate the expression of the three cell cycle-related phosphatases CDC25A, CDC25B and CDC25C in patients with ovarian cancer. All the patients had a minimal follow up of three years. CDC25A, CDC25B and CDC25C expression were investigated by immunohistochemistry in 106 patients with ovarian cancer. CDC25A and CDC25B were found expressed in almost all the samples analyzed, while CDC25C was undetectable in more than 80% of the patients. The low evaluable data on CDC25C expression, did not allow any association between the expression of this phosphatase and prognosis. The expression of CDC25A and CDC25B showed some evidences of association with a poor prognosis (p=0.034 and p=0.058 respectively). This relationship was independent of other factors such as tumor grade, histotype, stage and residual tumor after surgery. In the same patients the examined parameters (residual tumor, grade, stage and histotype) did show the expected relation with survival. The results indicate that high CDC25A and CDC25B expression is related to a worse prognosis in ovarian cancer patients. CDC25 phosphatases expression can be regarded as a possible prognostic factor for ovarian cancer and these proteins should be evaluated as potential molecular targets of novel drugs against this human neoplasm.

Original languageEnglish
Pages (from-to)4835-4840
Number of pages6
JournalAnticancer Research
Volume20
Issue number6 C
Publication statusPublished - 2000

Fingerprint

Phosphoric Monoester Hydrolases
Ovarian Neoplasms
Cell Cycle
Survival
Residual Neoplasm
Neoplasms
Cell Cycle Proteins
Immunohistochemistry
Pharmaceutical Preparations
Proteins

Keywords

  • Cell cycle proteins
  • Ovarian cancer
  • Prognostic factor

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients. / Broggini, M.; Buraggi, G.; Brenna, A.; Riva, L.; Codegoni, A. M.; Torri, V.; Lissoni, A. A.; Mangioni, C.; D'Incalci, M.

In: Anticancer Research, Vol. 20, No. 6 C, 2000, p. 4835-4840.

Research output: Contribution to journalArticle

Broggini, M, Buraggi, G, Brenna, A, Riva, L, Codegoni, AM, Torri, V, Lissoni, AA, Mangioni, C & D'Incalci, M 2000, 'Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients', Anticancer Research, vol. 20, no. 6 C, pp. 4835-4840.
Broggini, M. ; Buraggi, G. ; Brenna, A. ; Riva, L. ; Codegoni, A. M. ; Torri, V. ; Lissoni, A. A. ; Mangioni, C. ; D'Incalci, M. / Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients. In: Anticancer Research. 2000 ; Vol. 20, No. 6 C. pp. 4835-4840.
@article{a12a0f8b8f65488d9af5d157ea8511b5,
title = "Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients",
abstract = "Alterations in cell cycle regulating proteins are common in many cancer types. Recent data suggest a possible link between CDC25 phosphatases overexpression and malignancy. Our objective was to evaluate the expression of the three cell cycle-related phosphatases CDC25A, CDC25B and CDC25C in patients with ovarian cancer. All the patients had a minimal follow up of three years. CDC25A, CDC25B and CDC25C expression were investigated by immunohistochemistry in 106 patients with ovarian cancer. CDC25A and CDC25B were found expressed in almost all the samples analyzed, while CDC25C was undetectable in more than 80{\%} of the patients. The low evaluable data on CDC25C expression, did not allow any association between the expression of this phosphatase and prognosis. The expression of CDC25A and CDC25B showed some evidences of association with a poor prognosis (p=0.034 and p=0.058 respectively). This relationship was independent of other factors such as tumor grade, histotype, stage and residual tumor after surgery. In the same patients the examined parameters (residual tumor, grade, stage and histotype) did show the expected relation with survival. The results indicate that high CDC25A and CDC25B expression is related to a worse prognosis in ovarian cancer patients. CDC25 phosphatases expression can be regarded as a possible prognostic factor for ovarian cancer and these proteins should be evaluated as potential molecular targets of novel drugs against this human neoplasm.",
keywords = "Cell cycle proteins, Ovarian cancer, Prognostic factor",
author = "M. Broggini and G. Buraggi and A. Brenna and L. Riva and Codegoni, {A. M.} and V. Torri and Lissoni, {A. A.} and C. Mangioni and M. D'Incalci",
year = "2000",
language = "English",
volume = "20",
pages = "4835--4840",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "6 C",

}

TY - JOUR

T1 - Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients

AU - Broggini, M.

AU - Buraggi, G.

AU - Brenna, A.

AU - Riva, L.

AU - Codegoni, A. M.

AU - Torri, V.

AU - Lissoni, A. A.

AU - Mangioni, C.

AU - D'Incalci, M.

PY - 2000

Y1 - 2000

N2 - Alterations in cell cycle regulating proteins are common in many cancer types. Recent data suggest a possible link between CDC25 phosphatases overexpression and malignancy. Our objective was to evaluate the expression of the three cell cycle-related phosphatases CDC25A, CDC25B and CDC25C in patients with ovarian cancer. All the patients had a minimal follow up of three years. CDC25A, CDC25B and CDC25C expression were investigated by immunohistochemistry in 106 patients with ovarian cancer. CDC25A and CDC25B were found expressed in almost all the samples analyzed, while CDC25C was undetectable in more than 80% of the patients. The low evaluable data on CDC25C expression, did not allow any association between the expression of this phosphatase and prognosis. The expression of CDC25A and CDC25B showed some evidences of association with a poor prognosis (p=0.034 and p=0.058 respectively). This relationship was independent of other factors such as tumor grade, histotype, stage and residual tumor after surgery. In the same patients the examined parameters (residual tumor, grade, stage and histotype) did show the expected relation with survival. The results indicate that high CDC25A and CDC25B expression is related to a worse prognosis in ovarian cancer patients. CDC25 phosphatases expression can be regarded as a possible prognostic factor for ovarian cancer and these proteins should be evaluated as potential molecular targets of novel drugs against this human neoplasm.

AB - Alterations in cell cycle regulating proteins are common in many cancer types. Recent data suggest a possible link between CDC25 phosphatases overexpression and malignancy. Our objective was to evaluate the expression of the three cell cycle-related phosphatases CDC25A, CDC25B and CDC25C in patients with ovarian cancer. All the patients had a minimal follow up of three years. CDC25A, CDC25B and CDC25C expression were investigated by immunohistochemistry in 106 patients with ovarian cancer. CDC25A and CDC25B were found expressed in almost all the samples analyzed, while CDC25C was undetectable in more than 80% of the patients. The low evaluable data on CDC25C expression, did not allow any association between the expression of this phosphatase and prognosis. The expression of CDC25A and CDC25B showed some evidences of association with a poor prognosis (p=0.034 and p=0.058 respectively). This relationship was independent of other factors such as tumor grade, histotype, stage and residual tumor after surgery. In the same patients the examined parameters (residual tumor, grade, stage and histotype) did show the expected relation with survival. The results indicate that high CDC25A and CDC25B expression is related to a worse prognosis in ovarian cancer patients. CDC25 phosphatases expression can be regarded as a possible prognostic factor for ovarian cancer and these proteins should be evaluated as potential molecular targets of novel drugs against this human neoplasm.

KW - Cell cycle proteins

KW - Ovarian cancer

KW - Prognostic factor

UR - http://www.scopus.com/inward/record.url?scp=0034491671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034491671&partnerID=8YFLogxK

M3 - Article

C2 - 11205229

AN - SCOPUS:0034491671

VL - 20

SP - 4835

EP - 4840

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 6 C

ER -